Cell Culture Monitoring Biosensor Market Growth by 2028: Growth Rate, Manufacturers, Dynamics, Overview, Shipments, Revenue | C-CIT Sensors AG, Sarissa Biomedical Ltd, Lonza, Lifeonics ltd.,

Increasing Cell Culture Application in Research and Product Development to Augment Cell Culture Monitoring Biosensors Market Growth

The global cell culture monitoring biosensors market is estimated to be valued at US$ 332.0 million in 2020 and is expected to exhibit a CAGR of 9.6% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Cell culture is one of the major tools used in cellular and molecular biology, providing excellent model systems for studying the normal physiology and biochemistry of cells, effects of drugs and toxic compounds on the cells, and mutagenesis and carcinogenesis. Cell culture technique is often used to manufacture vaccines and biotechnology products. It is also used to develop a targeted drug therapy and identify potential biomarkers. While, biosensors are used to monitor several parameters (such as cell density, cell growth, contamination) and cellular behavior of cell culture. The application of cell culture is quite important and obvious in every research and product development in food, medicine, biotechnology, and other fields.

Acquire Sample Report + All Related Tables & Graphs Study Now @ https://www.coherentmarketinsights.com/insight/request-sample/219

Competitive Landscape:

Major players operating in the global cell culture monitoring biosensors market are Lifeonics ltd., Bruker Corporation, Cardea, Nova Biomedical, Lonza, Sarissa Biomedical Ltd., C-CIT Sensors AG, and Conductive Technologies Inc., among others.

Key Market Drivers:

High prevalence of chronic diseases, such as cancer, and increasing demand for monoclonal antibodies (mAbs) is expected to augment the growth of the cell culture monitoring biosensors market during the forecast period. For instance, according to the World Health Organization (WHO), cancer is one of the leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. The most common cancers are breast, lung, colon, and prostate cancers.

Moreover, growing demand for 3D cell culture and increase in funding or investment for cell-based research is expected to boost the growth of the cell culture monitoring biosensors market. For instance, in May 2019, TreeFrog Therapeutics raised around US$ 8.6 million in a Series A funding round for C-Stem, a 3D cell culture system used for mass-producing stem cells with short lead times while preserving genomic integrity.

COVID-19 Impact Analysis:

Governments worldwide have implemented nationwide lockdowns to curb the spread of the virus (COVID-19). The pandemic has also negatively impacted the medical device industry in terms of supply and demand of medical devices. As a result, the global cell culture monitoring biosensors market growth is also expected to witness a slowdown.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables& Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-pdf/219

Key Takeaways:

• The cell culture monitoring biosensors market is expected to exhibit a CAGR of 9.6% during the forecast period due to the increasing focus in the development of new drugs and therapies and growing focus on personalized medicine. For instance, in January 2022, TTP Plc. and CellFiber announced new strategic partnership to revolutionize cell manufacturing and provide much needed therapies to millions across the globe. Stem cell therapy has been shown to have a transformative impact in the treatment of some of the most devastating diseases, such as heart disease, diabetes, cancer, and Parkinson's disease.

• Among regions, North America, Europe, and Asia Pacific are expected to witness robust growth in the cell culture monitoring biosensors market owing to the rise in awareness of cell culture monitoring biosensors, increase in funding/investment for cell-based research, increase in production of biopharmaceuticals, increase in demand for targeted therapies, and increase in incidence of chronic diseases in these regions.

• For instance, in March 2019, Lonza launched CellBio Services, a comprehensive portfolio or solutions designed to meet specific, individual research application needs. Researchers across pharmaceutical and contract manufacturing organizations can now choose from an extensive range of services, including cell-line expansion and banking, media production, cell isolation, cell characterization, transfection services, and 3D cell-culture services.

Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/219

About US:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This release was published on openPR.